A model of the COVID-19 virus displayed at the National Institutes of Health, Thursday, Feb. 11, 2021, in Bethesda, Md. AP/Evan Vucci

A model of the COVID-19 virus displayed at the National Institutes of Health, Thursday, Feb. 11, 2021, in Bethesda, Md. AP/Evan Vucci

Here are 5 projects by companies tackling COVID-19 to watch in Canada

Provinces are sequencing COVID-positive samples at different rates for an average of about five per cent

It’s been a little more than a year since scientists and biotech companies around the world pivoted to understanding, treating and preventing COVID-19. Here are five projects to watch led by experts in Canada:

CanCOGeN

Led by Genome Canada, the Canadian COVID-19 Genomics Network aims to identify, understand and track faster spreading variants, including those first found in the United Kingdom, South Africa and Brazil. Tracking variants involves targeted and some random genomic sequencing of COVID-positive samples to determine if there’s a change in the virus’s genetic blueprint. The network’s executive director, Dr. Catalina Lopez-Correa, said the variants have spurred scientists to track changes to the virus at a speed and scale never seen before.

“Genomic epidemiology is now at the centre of our strategy to understand and control the COVID-19 pandemic,” she said.

The provinces are sequencing COVID-positive samples at different rates for an average of about five per cent across the country, she said. A new federal strategy focused on variants of concern is set to increase data sharing among researchers.

APN01

Data is expected soon from the phase two clinical trial for APN01, a treatment candidate for COVID-19 developed after the outbreak of SARS in 2002. Dr. Josef Penninger, the director of the University of British Columbia’s Life Sciences Institute, was working in Toronto at the time and helped pinpoint the key receptor by which SARS entered and began to replicate in human cells. It turns out the enzyme ACE2 is also the gateway into cells for the new coronavirus, said Penninger, who co-founded Apeiron Biologics.

The Austrian biotech company is now developing APN01 as a “soluble ACE2” therapy or drug to treat COVID-19 patients. It has “dual action,” Penninger said in a news release last fall, meaning it can both block the virus and also protect the lung, blood vessels or heart from injury. In September last year, the Lancet’s peer-reviewed respiratory medicine journal published a case report describing “significant clinical improvement” after APN01 was administered to a patient suffering from severe COVID-19.

Peptide possibilities

At the University of Regina, biochemist Mohan Babu is leading a team of researchers across Canada exploring how peptides – short chains of amino acids that make up proteins – could play a role in both diagnosing and treating COVID-19. They’re working to identify a peptide sequence that points to the illness in asymptomatic, mildly symptomatic and symptomatic patients, Babu explained. Their goal is to lay the foundation for a low-cost rapid test using saliva instead of the standard nasal swab and molecular (PCR) test.

“Those peptide signatures that are highly abundant in your saliva (are) going to be your diagnostic kit,” he said, adding the peptides are more stable and don’t degrade as quickly as the genetic material used in other tests.

On the treatment side, Babu said his team aims to “hijack” the virus using antiviral peptides that block it from entering and replicating inside human cells. They’re using a tiny part of the virus’s own sequence, coaxing it to bind to the ACE2 receptor, he said, while the remainder of the peptide sequence is randomized and the virus’s gateway into cells should wind up destroyed.

The researchers have so far identified four antiviral peptides that appear to inhibit the virus and they’re starting to test against several variants, said Babu. The results of their work have yet to pass through a peer-review process. Babu is receiving more than $900,000 in federal funding through the Canadian Institutes of Health Research for his research on COVID-19.

Blood biomarkers

Immunologists at Dalhousie University in Halifax are working with critical care specialists in Spain to examine key “biomarkers” in the blood of COVID-19 patients, which could help predict the severity of the illness. For a study published in the peer-reviewed journal Critical Care, they tested 250 patients with varying degrees of illness for ribonucleic acid or RNA – the virus’s “genetic blueprint” – and found 78 per cent of those who were severely ill had higher amounts of viral RNA than mild cases.

“We now have an extremely reliable indicator for identifying severe COVID-19 patients who require critical care and should be admitted to the ICU, which will help intensive care unit doctors prioritize severely ill patients,” said David Kelvin, Canada research chair at Dalhousie’s microbiology and immunology department, in a December statement.

The team also linked viral RNA to dysfunctional immune response among COVID-19 patients and they’re now examining how new variants of the virus affect host immunity compared with the first wave of the pandemic, he said. Their work is supported by the Canadian Institutes of Health Research.

Wastewater testing

Testing for COVID-19 in raw wastewater is scaling up in several provinces, including Ontario, B.C. and Nova Scotia. Gail Krantzberg, a professor in the engineering department at Hamilton’s McMaster University, said COVID-19 is “absolutely detectable” in many of the southern Ontario municipalities participating in the project.

A network of researchers at different universities is also working to make the testing more sensitive to detecting the virus. They recently had a sample and couldn’t detect it, but got a signal after refining their methods, said Krantzberg, adding the virus found in wastewater is “deactivated” and no longer live.

The researchers hope to use wastewater to sound the alarm about potential clusters in real time, before new individual cases are found, she said.

“People who are asymptomatic may not get tested. They’re walking around, they’re sick (and) nobody knows, even though they’re excreting (the virus).”

They should soon be able to deliver test results to health officials three times a week within 24 hours of sampling, said Krantzberg.

Brenna Owen, The Canadian Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Low interest rates have acted as a catalyst for the pandemic real estate market. (THE CANADIAN PRESS/Graeme Roy)
Real estate sales surging across Greater Victoria but risks lie ahead

Single family home prices jump nine per cent over past year while condo values remain stable

Passengers in rows 13 to 19 on Air Canada Jazz flight 8069 from Vancouver to Victoria Feb. 28 were exposed to a case of COVID-19. (THE CANADIAN PRESS/Nathan Denette)
COVID-19 exposure found on flight from Vancouver to Victoria

Passengers in rows 13 to 19 on Air Canada Jazz flight 8069 Feb. 28 affected

Environment Canada has issued a wind warning for Greater Victoria, with winds expected to get up to 70 km/h Friday morning. (Don Denton/Black Press Media)
Wind warning promises blustery Friday for Greater Victoria

Winds up to 70 km/h expected Friday morning

One person is dead after a camper van caught fire Thursday morning in Victoria's Beacon Hill Park. (Nina Grossman/News Staff)
UPDATED: One person dead after vehicle fire in Beacon Hill Park

Investigation into Victoria death in early stages

Darcy Rhodes (left) says his grandfather’s bonsai trees are his ‘babies.’ (Courtesy of Tamara Bond)
B.C. Health Minister Adrian Dix and provincial health officer Dr. Bonnie Henry head for the B.C. legislature press theatre to give a daily update on the COVID-19 pandemic, April 6, 2020. (B.C. government)
B.C. nears 300,000 COVID-19 vaccinations, essential workers next

564 new cases, four deaths, no new outbreaks Thursday

Anyone with information on any of these individuals is asked to call 1-800-222-TIPS (8477) or visit the website victoriacrimestoppers.ca for more information.
Greater Victoria Crime Stoppers wanted list for the week of March 2

Greater Victoria Crime Stoppers is seeking the public’s help in locating the… Continue reading

(Black Press Media file photo)
POLL: How’s your butter?

Recent reports have some Canadians giving a second look to one of… Continue reading

(Pxhere)
B.C. research reveals how pandemic has changed attitudes towards sex, health services

CDC survey shows that 35 per cent of people were worried about being judged

The intersection of Melrose Street and Third Avenue. (ELENA RARDON / ALBERNI VALLEY NEWS)
Suspect in custody after two pedestrians struck in Port Alberni hit and run

RCMP asking for video footage, credit witnesses for quick arrest

(National Emergency Management Agency)
No tsunami risk to B.C. from powerful New Zealand earthquake: officials

An 8.1 magnitude earthquake shook the north of New Zealand Thursday morning

(AP Photo/Richard Vogel, File)
Pandemic stress, isolation key factors as to why Canadians turned to cannabis, alcohol

Study found that isolation played key role in Canadians’ substance use

Comox Valley RCMP had access to 20 Street blocked off between Cousins and Choquette avenues as they conducted a raid of a house on the block. Photo by Terry Farrell
Comox Valley RCMP raid Courtenay problem house, several arrests made

Comox Valley RCMP conducted a raid of a problem house on 20th… Continue reading

Some Canadians are finding butter harder than usual, resulting in an avalanche of social media controversy around #buttergate. (Brett Williams/The Observer)
#Buttergate: Concerns around hard butter hit small B.C. towns and beyond

Canadians find their butter was getting harder, blame palm oil in part one of this series

Most Read